Skip to main content
Premium Trial:

Request an Annual Quote

UK s BII, Lucidyx Pen Bioinformatics Co-Development Alliance

This article has been corrected from a previous version, which described Lucidyx as a British company. The firm is based in Westlake, Ohio.

NEW YORK, June 24 (GenomeWeb News) - The Biosystems Informatics Institute and Lucidyx will co-develop new bioinformatics tools to integrate data storage and Lucidyx's genomic search engine in an attempt to "better contextualize off-target drug effects," the groups said yesterday.

These tools may play a role in researchers' attempts to "further understand the data flowing from proteomics and transcriptomics experiments across the industry," Ian Humphrey-Smith, chief executive officer of the BII, said in a statement.

Terms of the agreement between the groups call for BII to help Lucidyx develop products that could enable life-science software researchers developing tools to access genomic data through application programming interfaces to query and retrieve information from Lucidyx's genomic annotation search engine Searcher.

The collaboration "focuses" on the development of Lucidyx Oracle Gateway, designed to be a "bridge" between Oracle and the Lucidyx search engine that allows Oracle SQL queries to combine data from Oracle with data from Searcher "as if all the data was stored in Oracle tables," according to the statement.


Financial terms of the alliance were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.